Amadeus Capital Partners is a global technology investor backing early-stage and growth companies with international potential. Founded in 1997 by Anne Glover and Hermann Hauser, the firm has raised over $1 billion and invested in more than 190 companies across deep tech sectors including AI, cybersecurity, digital health, and quantum technologies. Headquartered in London with offices in Cambridge, Oxford, San Francisco, and São Paulo, Amadeus maintains a strong presence in global innovation hubs. One-third of its early-stage investment professionals are women, reflecting its commitment to diversity within its team and portfolio.

In the period between 2018 to June 2025, the firm invested in 45 UK companies in 86 fundraising rounds. The average turnover of those companies was £6.67m and their average number of employees was 56.

Scaleups within Amadeus Capital Partners portfolio include PhoreMost, a biotech company and Secondmind, a firm that develops machine learning algorithms. 

The firm follows three investment strategies: providing seed, start-up and scaleup capital for early stage companies with exceptional IP based in, or growing from the UK; primary and secondary investments in high-growth technology companies; and growth capital investments in tech-enabled consumer and business services in emerging markets. It is focused on AI & machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech and insurtech. 

It is a partner with the British Business Bank on the Enterprise Capital Fund programme. Its latest £110m Amadeus V Technology Fund includes a cornerstone commitment by British Patient Capital.

Amadeus Capital Partners, the Cambridge-headquartered deep-tech venture capital firm, maintained its focus on high-growth, science-backed UK companies in 2025 while celebrating significant exits. The firm secured a major success with the acquisition of its portfolio company Ravelin by Worldpay, underscoring its ability to scale AI-native fraud prevention platforms into valuable assets. This exit aligns with its ongoing strategy of backing ventures in core sectors like Artificial Intelligence, Quantum Technologies, and Digital Health. Amadeus also continued to deploy capital from its active funds, focusing on early-stage deep-tech companies emerging from UK science hubs like Cambridge and Oxford.

Amadeus Capital Partners website